Georgy Bakalkin

Prof. Georgy Bakalkin

orcid

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2006 in Experimental Cell Research
Verified
Journal Article
Closed access
MKMohsen Karimi
Mohsen Karimi
SJSofia Johansson
Sofia Johansson
DSDirk Stach
Dirk Stach
MCMartin Corcoran
Martin Corcoran
DGDan Grandér
Dan Grandér
TETomas J. Ekström
Tomas J. Ekström

28 November 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
GSGunter Schumann
Gunter Schumann
CLChunyu Liu
Chunyu Liu
POPaul O’reilly
Paul O’reilly
HGHe Gao
He Gao
PSParkyong Song
Parkyong Song
PEPaul Elliott
Paul Elliott
Excessive alcohol consumption is a major public health problem worldwide. Although drinking habits are known to be inherited, few genes have been identified that are robustly linked to alcohol drinking. We conducted a genome-wide association metaanalysis and replication study among >105,000 individuals of European ancestry and identified β-Klotho (KLB) as a locus associated with alcohol consumption (rs11940694; P = 9.2 × 10−12). β-Klotho is an obligate coreceptor for the hormone FGF21, which is secreted from the liver and implicated in macronutrient preference in humans. We show that brain-specific β-Klotho KO mice have an increased alcohol preference and that FGF21 inhibits alcohol drinking by acting on the brain. These data suggest that a liver–brain endocrine axis may play an important role in the regulation of alcohol drinking behavior and provide a unique pharmacologic target for reducing alcohol consumption. Significance Alcohol is a widely consumed drug in western societies that can lead to addiction. A small shift in consumption can have dramatic consequences on public health. We performed the largest genome-wide association metaanalysis and replication study to date (>105,000 individuals) and identified a genetic basis for alcohol consumption during nonaddictive drinking. We found that a locus in the gene encoding β-Klotho is associated with alcohol consumption. β-Klotho is an essential receptor component for the endocrine FGFs, FGF19 and FGF21. Using mouse models and pharmacologic administration of FGF21, we show that β-Klotho in the brain controls alcohol drinking. These findings reveal a mechanism regulating alcohol consumption in humans that may be pharmacologically tractable for reducing alcohol intake.

6 April 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GSGunter Schumann
Gunter Schumann
LCLachlan J. Coin
Lachlan J. Coin
Anbarasu LourdusamyAnbarasu Lourdusamy
Anbarasu Lourdusamy
PCPimphen Charoen
Pimphen Charoen
KBKaren H. Berger
Karen H. Berger
PEPaul Elliott
Paul Elliott
Alcohol consumption is a moderately heritable trait, but the genetic basis in humans is largely unknown, despite its clinical and societal importance. We report a genome-wide association study meta-analysis of ∼2.5 million directly genotyped or imputed SNPs with alcohol consumption (gram per day per kilogram body weight) among 12 population-based samples of European ancestry, comprising 26,316 individuals, with replication genotyping in an additional 21,185 individuals. SNP rs6943555 in autism susceptibility candidate 2 gene ( AUTS2 ) was associated with alcohol consumption at genome-wide significance ( P = 4 × 10 −8 to P = 4 × 10 −9 ). We found a genotype-specific expression of AUTS2 in 96 human prefrontal cortex samples ( P = 0.026) and significant ( P < 0.017) differences in expression of AUTS2 in whole-brain extracts of mice selected for differences in voluntary alcohol consumption. Down-regulation of an AUTS2 homolog caused reduced alcohol sensitivity in Drosophila ( P < 0.001). Our finding of a regulator of alcohol consumption adds knowledge to our understanding of genetic mechanisms influencing alcohol drinking behavior.

4 January 1994 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
GBGeorgy Bakalkin
Georgy Bakalkin
TYT Yakovleva
T Yakovleva
GSGalina Selivanova
Galina Selivanova
KMKristinn Magnússon
Kristinn Magnússon
LSL Szekely
L Szekely
KWK G Wiman
K G Wiman
The p53 tumor-suppressor protein has previously been shown to bind double-stranded and single-stranded DNA. We report that the p53 protein can bind single-stranded DNA ends and catalyze DNA renaturation and DNA strand transfer. Both a bacterially expressed wild-type p53 protein and a glutathione S-transferase-wild-type p53 fusion protein catalyzed renaturation of different short (25- to 76-nt) complementary single-stranded DNA fragments and promoted strand transfer between short (36-bp) duplex DNA and complementary single-stranded DNA. Mutant p53 fusion proteins carrying amino acid substitutions Glu-213, Ile-237, or Tyr-238, derived from mutant p53 genes of Burkitt lymphomas, failed to catalyze these reactions. Wild-type p53 had significantly higher binding affinity for short (36- to 76-nt) than for longer (> or = 462-nt) single-stranded DNA fragments in an electrophoretic mobility-shift assay. Moreover, electron microscopy showed that p53 preferentially binds single-stranded DNA ends. Binding of DNA ends to p53 oligomers may allow alignment of complementary strands. These findings suggest that p53 may play a direct role in the repair of DNA breaks, including the joining of complementary single-stranded DNA ends.

11 February 1995 in Nucleic Acids Research
Verified
Journal Article
Closed access
PDF file
GBGeorgy Bakalkin
Georgy Bakalkin
GSGalina Selivanova
Galina Selivanova
TYTatjana Yakovleva
Tatjana Yakovleva
EKElena Kiseleva
Elena Kiseleva
Elena KashubaElena Kashuba
Elena Kashuba
KWKlas G. Wiman
Klas G. Wiman
We have previously reported that wild-type p53 can bind single-stranded (ss) DNA ends and catalyze renaturation of ss complementary DNA molecules. Here we demonstrate that p53 can also bind to internal segments of ss DNA molecules via a binding site (internal DNA site) distinct from the binding site for DNA ends (DNA end site). Using p53 deletion mutants, the internal DNA site was mapped to the central region (residues 99–307), while the DNA end site was mapped to the C-terminal domain (residues 320–393) of the p53 protein. The internal DNA site can be activated by the binding of ss DNA ends to the DNA end site. The C-terminal domain alone was sufficient to catalyze DNA renaturation, although the central domain was also involved in promotion of renaturation by the full-length protein. Our results suggest that the interaction of the C-terminal tail of p53 with ss DNA ends generated by DNA damage in vivo may lead to activation of non-specific ss DNA binding by the central domain of p53.

1 October 2011 in American Journal of Psychiatry
Verified
Journal Article
Closed access
LDLi Dong
Li Dong
ABAinhoa Bilbao
Ainhoa Bilbao
MLManfred Laucht
Manfred Laucht
RHRichard Henriksson
Richard Henriksson
TYTatjana Yakovleva
Tatjana Yakovleva
GSGunter Schumann
Gunter Schumann